The first pilot study of local injections of [213Bi]Bi-DOTA-[Thi8,Met(O2)11]-substance P ([213Bi]Bi-DOTA-SP) was performed in patients with critically localized gliomas (15). This evidence concerns the gene TAC1 and glioma.